Inform Diagnostics, the nation’s largest independent anatomic pathology
lab, has worked closely with Wolters Kluwer throughout its latest software
release of ProVation® MD to
automatically populate the pathology section of the GIQuIC form for single colonoscopies, which will save hours of time for clients. Inform Diagnostics
Life Sciences’ use of structured diagnostic terminology combined
with its pathology interface to ProVation MD facilitates this automation.
The new software release also automates the ProVation MD Adenoma Detection
Rate report for physicians, which utilizes pathology data from Inform Diagnostics
When Inform Diagnostics pathology reports are sent electronically via
ProVation MD to ambulatory surgery centers (ASCs) and endoscopy centers,
the structured diagnostic data flows directly into the patient chart,
enabling ProVation MD to immediately utilize this data for reporting purposes.
Practices and centers using both ProVation MD and Inform Diagnostics
will have applicable pathology reports included in the Adenoma Detection
Rate (ADR) report. Staff submitting PQRS data through GIQuIC for these
procedures will need only to enter each patient’s follow-up interval.
“Inform Diagnostics has a long-standing relationship with Wolters
Kluwer and ProVation MD, to develop innovative solutions for clinicians,”
said Tom Zaves, Senior Vice President of Sales and Product Strategy for
Inform Diagnostics. “This new reporting capability furthers our
commitment to clinicians to help them meet reporting requirements and
What is ProVation MD?
The only structured reporting and coding solution that provides clinically
relevant, intuitive software for more accurate and complete documentation
of procedures, ProVation MD Gastroenterology allows physicians to effectively
capture robust detail from even the most complex procedures. It then automatically
generates clear, complete procedure notes and appropriate reimbursement codes.
What is GIQuIC?
The GI Quality Improvement Consortium, Ltd.—GIQuIC—is a non-profit
collaboration of the American College of Gastroenterology (ACG) and the
American Society for Gastrointestinal Endoscopy (ASGE), providing a quality
benchmarking registry. Physicians are participating by collecting and
submitting data about their colonoscopies. Participation in GIQuIC enables
practices and centers to participate in PQRS (Physician Quality Report
System) in order to avoid penalties by the Centers for Medicaid and Medicare
What is the Adenoma Detection Rate?
ADR is one clinical quality measure that a provider can report to CMS
to participate in PQRS. The rate is calculated using pathology data for
colonoscopies performed by the provider. The ASGE has stated that a physician’s
adenoma detection rate during colonoscopies is a good indicator of quality—a
high rate is associated with low post-colonoscopy rates of colorectal cancer.
Inform Diagnostics provides fee-based consulting services to help clients
understand their options for quality reporting and how to embed quality
reporting into their practice or center. Quality reporting such as via
GIQuIC is required for participation in the CMS programs Value-Based Modifiers
and Merit-Based Incentive Payment System (MIPS) as the industry goes to
a pay-for-performance model.
About Inform Diagnostics
Inform Diagnostics provides the highest quality anatomic pathology services,
primarily in the fields of dermatology, hematology, gastroenterology,
urology, and breast health. The company’s team of more than 90 distinguished
expert subspecialists utilizes state-of-the-art pathology laboratories
to serve more than 5,500 patients every day. Inform Diagnostics continuously
improves diagnostic precision through consensus-based terminology and
criteria, rigorous quality assurance, daily consensus conferences, extensive
educational and training activities, and close relationships with clinical
partners. Headquartered in Irving, Texas, Inform Diagnostics Life Sciences is a subsidiary
of Inform Diagnostics Holdings Inc., Japan’s largest clinical diagnostics and
laboratory testing service provider. For more information, visit www.MiracaLifeSciences.com.
Media contact information:
Joy Jennings, Director of Marketing